This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Evidence that the multiflorine‐derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α
2
‐adrenoceptors in mice, Diabetes Obesity and Metabolism, November 2019, Wiley,
DOI: 10.1111/dom.13895.
You can read the full text:
The following have contributed to this page
